Skip to main content
Clinical Trials/NCT04602026
NCT04602026
Completed
Not Applicable

Re-Defining Frailty and Improving Outcomes Through Prehabilitation (RIOT Trial)

Ohio State University Comprehensive Cancer Center1 site in 1 country66 target enrollmentSeptember 14, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adult Liver Carcinoma
Sponsor
Ohio State University Comprehensive Cancer Center
Enrollment
66
Locations
1
Primary Endpoint
Morbidity
Status
Completed
Last Updated
last year

Overview

Brief Summary

This trial studies how well a prehabilitation program works to improve patient outcomes after surgery compared to the normal standard of care prehabilitation in frail patients undergoing surgery for pancreatic, liver, or gastric cancer. Frailty is defined as the pathophysiology of aging or through the accumulation of physiologic and functional deficits. Prehabilitation programs seek to optimize the medical and physical state of patients prior to undergoing surgery with the goal of improving outcomes following surgery. Despite evidence for its importance in health outcomes for frail patients, prehabilitation programs have not been well studied in cancer surgery populations. This trial may provide researchers with more information on how to improve patient outcomes after cancer surgery through the use of prehabilitation programs.

Detailed Description

PRIMARY OBJECTIVES: I. To develop a novel, multi-dimensional index of physiologic reserve and resilience specific to surgical cancer patients. II. To implement and assess a novel comprehensive multidimensional prehabilitation program on frail cancer surgery patients. OUTLINE: All patients enrolled (both frail and non-frail) will be randomized (1:1) at the time of enrollment to receive pre-operative exercise or non-preoperative exercises. Randomization will be stratified by frailty status. ARM I: Enrolled patients undergo a physical therapy consultation and complete home exercises 3 days per week, in addition to standard guidelines. ARM II: Enrolled patients follow standard guidelines. All patients are followed up at 2 weeks after surgery and then every 3 months.

Registry
clinicaltrials.gov
Start Date
September 14, 2020
End Date
December 9, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mark Rubinstein

Principal Investigator

Ohio State University Comprehensive Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Scheduled for any abdominal (e.g., pancreatic, liver or gastric) cancer surgery or established in the GI surgical oncology clinics or
  • Scheduled for neoadjuvant therapy prior with the plan to be scheduled for surgery

Exclusion Criteria

  • Non-English speaking
  • Prisoners
  • Persons unable to provide informed consent

Outcomes

Primary Outcomes

Morbidity

Time Frame: Baseline

Will be assessed using standardized case report forms.

Frailty assessment

Time Frame: Baseline

A rapid assessment for frailty using the widely used 5-item fatigue, resistance, ambulation, illness, \& loss of weight (FRAIL) questionnaire will be performed. Patients are identified as frail by scoring 2 or more points on the FRAIL questionnaire. The frailty assessment will be aimed at identifying factors related to the 6 characteristics of frailty: physical performance, gait speed, mobility, nutritional status, mental health and cognition.

Health-related quality of life (composite measure)

Time Frame: Baseline, 2 weeks, 3, 6, 12 months

Will be recorded by administration of the Patient Reported Outcomes Measurement Information System (PROMIS) health-related quality of life questionnaire. PROMIS is a validated set of patient-centered measures that evaluates and monitors life domains (physical, mental, social health) and provide standardized patient reported outcome resources for use in clinical research and practice.

Complication burden

Time Frame: Baseline

Will be calculated using the Comprehensive Complication Index (CCI). This method is more powerful than standard binary measures of morbidity (presence/absence of individual events) as it presents a quantitative score based on an aggregate weighted total ranging from 0 (no complications) to 100 (death).

Study Sites (1)

Loading locations...

Similar Trials